Evaluation of Protein Kinase Inhibitors with PLK4 Cross-Over Potential in a Pre-Clinical Model of CancerAmreena Suri(Lurie Children's Hospital), Simone Treiger Sredni(AstraZeneca (Netherlands))International Journal of Molecular SciencesApril 29, 201910.3390/ijms20092112Cited by 46SaveCiteExport RISWatch citationsRelated PapersCharacterization of brain tumor initiating cells isolated from an animal model of CNS primitive neuroectodermal tumors|Oncotarget|2018|9